๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The mechanism of action of cyclosporin A and FK506

โœ Scribed by Stuart L Schreiber; Gerald R Crabtree


Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
770 KB
Volume
13
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


FK-506 and cyclosporin A : immunosuppres
โœ John J Siekierka; Nolan H Sigal ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 725 KB

Cyclosporin A and FK-506 are important therapeutic agents that have found widespread use in preventing graft rejection during tissue transplantation. Research efforts aimed at elucidating the molecular mechanism of action of these drugs have, in addition to defining their immunosuppressive functions

Distribution characteristics of immunosu
โœ Kanji Takada; Naohisa Katayama; Akiko Kiriyama; Hisato Usuda ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 781 KB

Using two representative immunosuppressants, FK506 (FK) and cyclosporin A (CyA), of which the mechanism of pharmacological action is the same although there is a great difference in the pharmacological intensity, the distribution characteristics were studied in both in vivo and in vitro experiments

Suppression of B cell activation by cycl
โœ Linda S. Wicker; Robert C. Boltz Jr.; Victoria Matt; Elizabeth A. Nichols; Laure ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 722 KB

## Abstract The effects of the immunosuppressants cyclosporin A (CsA), FK506 and rapamycin have been compared using murine B cells activated with a variety of mitogens. FK506 is a macrolide antibiotic that has been recently shown to inhibit T cell activation by a mechanism that appears similar to t

Late hypertension after liver transplant
โœ Canzanello, Vincent J. ;Textor, Stephen C. ;Taler, Sandra J. ;Schwartz, Lora L. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 198 KB

Hypertension frequently develops early after liver transplantation when cyclosporine-based immunosuppression is used. However, initial experience with tacrolimus has suggested that its use leads to a lower early incidence of hypertension. In this study, the blood pressure status of patients treated